专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US4863740A Interleukin therapy 失效
标题翻译：白介素治疗
公开(公告)号：US4863740A
公开(公告)日：1989-09-05
申请号：US193423
申请日：1988-05-12
申请人： Thomas Kissel , Jurg Reinhardt , Henriette Schrank
发明人： Thomas Kissel , Jurg Reinhardt , Henriette Schrank
IPC分类号： A61K38/16 , A61K9/127 , A61K9/50 , A61K38/00 , A61K38/20
CPC分类号： A61K9/1277 , A61K38/2013 , A61K9/127
摘要： Interleukin-2 liposomes are advantageous sustained release formulations.
摘要翻译：白介素-2脂质体是有利的持续释放制剂。

2. 发明授权

US5364628A Pharmaceutical compositions 失效
标题翻译：药物组合物
公开(公告)号：US5364628A
公开(公告)日：1994-11-15
申请号：US141832
申请日：1993-10-22
申请人： Thomas Kissel , Henriette Schrank , Hans-Rainer Hoffmann
发明人： Thomas Kissel , Henriette Schrank , Hans-Rainer Hoffmann
IPC分类号： A61K9/70 , A61K31/40 , A61F13/02
CPC分类号： A61K9/7061 , A61K31/40 , A61K9/7084
摘要： The present invention provides a pharmaceutical composition for the transdermal systemic administration of an active agent characterized in that the active agent is bopindolol or methysergide. Also the present invention provides a pharmaceutical composition for the transdermal systemic administration of a pharmacologically active agent characterized in that it contains bopindolol, tizanidine, clemastine, ketotifen or methysergide as active agent in a reservoir comprising a hydrophilic polymer. Furthermore a pharmaceutical composition for the transdermal systemic administration of pharmacologically active agents characterised in that the pharmacologically active agent is in a reservoir comprising a polyacrylate polymer containing cationic ester groups.
摘要翻译：本发明提供了一种用于经皮全身给药活性剂的药物组合物，其特征在于活性剂是苯吲哚洛尔或甲基麦角苷。本发明还提供了一种药物组合物，其用于药理学活性剂的经皮系统性给药，其特征在于在包含亲水性聚合物的储库中含有苯妥萘洛，替扎尼定，克立马斯酮，酮替芬或甲基麦角苷作为活性剂。此外，用于经皮系统施用药理活性剂的药物组合物，其特征在于药理活性剂在包含含有阳离子酯基的聚丙烯酸酯聚合物的储库中。

3. 发明授权

US5593686A Pharmaceutical compositions 失效
标题翻译：药物组合物
公开(公告)号：US5593686A
公开(公告)日：1997-01-14
申请号：US314167
申请日：1994-09-28
申请人： Thomas Kissel , Henriette Schrank , Hans-Rainer Hoffmann
发明人： Thomas Kissel , Henriette Schrank , Hans-Rainer Hoffmann
IPC分类号： A61K9/70 , A61K31/40 , A61F13/02
CPC分类号： A61K9/7061 , A61K31/40 , A61K9/7084
摘要： The present invention provides a pharmaceutical composition for the transdermal systemic administration of an active agent characterized in that the active agent is bopindolol or methysergide. Also the present invention provides a pharmaceutical composition for the transdermal systemic administration of a pharmacologically active agent characterized in that it contains bopindolol, tizanidine, clemastine, ketotifen or methysergide as active agent in a reservoir comprising a hydrophilic polymer. Furthermore a pharmaceutical composition for the transdermal systemic administration of pharmacologically active agents characterized in that the pharmacologically active agent is in a reservoir comprising a polyacrylate polymer containing cationic ester groups.
摘要翻译：本发明提供了一种用于经皮全身给药活性剂的药物组合物，其特征在于活性剂是苯吲哚洛尔或甲基麦角苷。本发明还提供了一种药物组合物，其用于药理学活性剂的经皮系统性给药，其特征在于在包含亲水性聚合物的储库中含有苯妥萘洛，替扎尼定，克立马斯酮，酮替芬或甲基麦角苷作为活性剂。此外，用于经皮系统施用药理活性剂的药物组合物，其特征在于药理活性剂在包含含有阳离子酯基的聚丙烯酸酯聚合物的储库中。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式